Please login to the form below

Not currently logged in
Email:
Password:

AZ to sell Astra Tech for $1.8bn

AstraZeneca is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn

AstraZeneca (AZ) is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn.

Dentsply, a US-based dental equipment maker, is anticipated to complete the acquisition in the second half of 2011.

Astra Tech consists of a dental division, focusing on the research, development, manufacturing and marketing of dental implants; and a healthcare division, focusing on medical devices for use primarily in urology and surgery.

Worldwide revenue for Astra Tech was recorded as $535m for 2010.

"Following a comprehensive strategic review, we believe this transaction represents an excellent outcome for AstraZeneca shareholders," said David Brennan, CEO, AZ. "The high degree of interest and the competitive nature of this process is evidence of the value that the employees of Astra Tech have built in the marketplace."

22nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics